This was highlighted today by the Regional Minister for Economy, Finance and Employment, Rocío Albert, during her visit to Italfarmaco’s headquarters in Milan, on the first day of her institutional visit to Italy aimed at showcasing the region’s economic strengths and continuing to attract foreign capital.
Albert emphasized the “legal and institutional” security offered by Madrid, with an Administration that “supports those who create wealth, without putting obstacles in their way, by eliminating obsolete regulations and procedures and offering the most competitive taxation in Spain.”
Thanks to these policies, Albert noted, the Madrid economy attracts nearly 70% of foreign investment in 2024, amounting to more than €26.4 billion. In addition, it is the national leader in high value-added industries such as pharmaceuticals, with 78 companies representing 22.1% of the sector and a turnover of €5.106 billion, accounting for 25.7% of the total in Spain. As for exports, they reached €7.469 billion over the same period, representing 42.3% of the national total, with strong growth compared to pre-pandemic levels.
The strong link between Italfarmaco and the region is also highlighted, as well as its headquarters in Alcobendas, which specializes in the manufacture of softgel capsules for international markets and is one of the group’s flagship plants. At this facility, the Italian company will invest €10 million to open a new production line aimed at improving process efficiency and increasing industrial capacity. During the meeting with Albert, potential new projects for the city of Alcobendas were also discussed